Skip to content
Orbit Insight

The Zimbabwean Government Turns Down ‘One-Sided’ American Health Aid Agreement Because of Information Fears

Medical funding image
The offered US financial assistance would have supported initiatives for HIV/Aids treatment and prevention, TB, and malaria.

Zimbabwe has declined a major US healthcare agreement valued at $367m (272 million pounds) spanning five years because of the United States' insistence on sensitive information.

This move became public following a government memo from December was leaked, indicating that President Emmerson Mnangagwa deemed the deal was "skewed".

An official spokesperson later explained that the United States was requesting genetic material for scientific study and profit but refused to share the benefits from future treatments.

"We must now begin the difficult and regrettable task of scaling back our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy noted the US had provided over $1.9bn for health programmes to Zimbabwe during the past two decades.

A physicians' group in Zimbabwe has appealed for more negotiations to find a agreement agreeable to both sides so the nation's critical HIV programme can proceed.

Wider Implications

This rejection comes after a comparable case in Kenya, where a court halted a similar deal with the US after concerns were filed about the security of citizens' medical information.

Since resuming the presidency last year, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).

USAID had managed assistance for the American government, but Trump stated its expenditure was "inefficient" and his administration was pursuing direct bilateral deals to boost openness and responsibility.

Based on statements, 16 African countries have so far signed these new agreements, representing over $18.3bn in new funding.

Details of the Rejected Deal

The funds for Zimbabwe would have funded "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.

"It is our view this collaboration would have delivered extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million currently receiving HIV treatment through US-supported initiatives," the Ambassador commented.

However, government spokesperson Nick Mangwana said the proposed deal was "asymmetrical".

"Zimbabwe was being asked to provide its genetic material and health information over an extended period, with no corresponding guarantee of access to any medical innovations – such as new medicines or tests – that could result from that provided information," his statement read.

"In essence, our nation would supply the basic resources for medical research without any assurance that the final treatments would be available to our population if a future disease outbreak arise."

Sovereignty and Global Health

He also pointed out that the American exit from the global health body and its push of one-on-one health agreements were upending frameworks previously set up via the global organization.

The spokesperson gave as an example its Pandemic Benefit-Sharing scheme designed to manage future pandemics.

"This framework is designed to guarantee that when a country contributes its samples, the resulting advantages – such as medicines and cures – are shared equitably, not monopolised solely by those with the resources to create them."

The government's concerns regarding the US deal "must not be interpreted as opposition to America," Mangwana stressed.

"We encourage continued dialogue with our US partners on how subsequent collaboration might be arranged in a way that respects the independence and dignity of each country."

Medical Community Response

A leading public health body stated it acknowledged the official position, but recommended that talks need to persist given that much of the nation's HIV programmes relied on international support.

"In cases where technical issues exist, such as those relating to information security or agreement terms, these can often be addressed through technical clarification and negotiated safeguards," it said.

This impasse emphasises the complex challenges between receiving vital international aid and safeguarding local interests in an ever more interconnected world.

The writer

Adam Bradley

A technology strategist with over a decade of experience in digital transformation and innovation consulting.

Orbit Insight

Type to search articles.